Approach: antisense oligonucleotides targeting microRNA

​

    Website

​

   Updates:

​

        July 23, 2020: Article discussing raise of 4.25 million euros in funding

        July 2021 study  Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy

        June 10, 2022 presentation for Myotonic Dystrophy Foundation

​

​